| |
Parasite serology negative (n= 136) |
Parasite serology positive (n= 14) |
p value |
| Male, n (%) |
94 (69) |
11 (79) |
0.46 |
| Age (years)* |
69 (0.8) |
64.5 (3) |
0.24 |
| Body mass index (kg/m2) |
26 (0.4) |
27 (1.7) |
0.73 |
| Pack years smoked |
46 (30-60) |
39 (28-79) |
0.89 |
| Exacerbations in last year |
3 (1-5) |
2 (0-7.5) |
0.68 |
| ICS (BDP equivalent) (mcg/day) |
2000 (900-2000) |
2000 (800-2000) |
0.86 |
| FEV1% predicted, (%) |
49 (1.7) |
45.7 (4.8) |
0.69 |
| FEV1/FVC (%) * |
49 (1.1) |
50 (3.2) |
0.80 |
| Reversibility, % |
3.7(-1.3- 10) |
0.69(-6.2- 6.7) |
0.10 |
| Sputum TCCx106/g |
3.6 (1.5-7.9) |
1.8 (0.75-4.5) |
0.06 |
| Sputum neutrophils (%) |
73 (53-89) |
60 (37-77) |
0.11 |
| Sputum eosinophils (%) |
1.0 (0.25-3) |
0.75 (0.44-2.1) |
0.89 |
| AUC sputum eosinophils %/year |
0.79 (0.27-1.1) |
0.41 (0.25-2.2) |
0.30 |
| PB. eosinophils (x109/L) |
0.22 (0.13 - 0.34) |
0.17 (0.09 - 0.29) |
0.22 |
| MRC Dyspnoea Scale |
3 (2-4) |
3 (2-3) |
0.44 |
| SGRQ Total Score* |
51 (1.6) |
56 (4.4) |
0.34 |
| CRQ total score* |
16 (0.41) |
17 (0.95) |
0.47 |
| VAS Cough (mm) |
33 (13-54) |
30 (13-72) |
0.93 |
| VAS Dyspnoea (mm) |
46 (23-67) |
50 (24-69) |
0.79 |
| VAS Sputum Production (mm) |
31 (11-55) |
37 (6-55) |
0.96 |
| VAS Sputum Purulence (mm) |
21 (8-49) |
26 (10-51) |
0.82 |
